Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic review
出版年份 2021 全文链接
标题
Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic review
作者
关键词
Ketamine, Functioning, Depression, Mood disorder, Recovery, Workplace, Bipolar Disorder
出版物
JOURNAL OF AFFECTIVE DISORDERS
Volume 293, Issue -, Pages 285-294
出版商
Elsevier BV
发表日期
2021-06-25
DOI
10.1016/j.jad.2021.06.032
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Does pre-treatment functioning influence response to intravenous ketamine in adults with treatment-resistant depression?
- (2021) Roger S McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- The Effectiveness of Repeated Intravenous Ketamine on Depressive Symptoms, Suicidal Ideation and Functional Disability in Adults with Major Depressive Disorder and Bipolar Disorder: Results from the Canadian Rapid Treatment Center of Excellence
- (2020) Roger S McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- (2020) Theo Vos et al. LANCET
- Burden of Treatment Resistant Depression (TRD) in patients with major depressive disorder in Ontario using Institute for Clinical Evaluative Sciences (ICES) databases: Economic burden and healthcare resource utilization
- (2020) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Bipolar disorders
- (2020) Roger S McIntyre et al. LANCET
- The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future Research
- (2020) Hartej Gill et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis
- (2020) Jiaqi Xiong et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Current and Common Definitions of Treatment-Resistant Depression: Findings from a Systematic Review and Qualitative Interviews
- (2019) Sage Brown et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
- (2019) Vanina Popova et al. AMERICAN JOURNAL OF PSYCHIATRY
- Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class
- (2019) Jean Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
- (2019) Maggie Fedgchin et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3
- (2019) Rachel Ochs-Ross et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Cognitive Impairment Mediates Workplace Impairment in Adults With Type 2 Diabetes Mellitus: Results From the Motivaction Study
- (2018) Yena Lee et al. Canadian Journal of Diabetes
- The burden of treatment-resistant depression: a systematic review of the economic and quality of life literature
- (2018) Karissa Johnston et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review
- (2018) Yena Lee et al. JOURNAL OF AFFECTIVE DISORDERS
- Repeated intranasal ketamine for treatment-resistant depression – the way to go? Results from a pilot randomised controlled trial
- (2018) Verònica Gálvez et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
- (2018) Ella J. Daly et al. JAMA Psychiatry
- Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression
- (2018) Joshua D. Rosenblat et al. JOURNAL OF AFFECTIVE DISORDERS
- Reducing the global burden of depression: a Lancet–World Psychiatric Association Commission
- (2018) Helen Herrman et al. LANCET
- Restoring function in major depressive disorder: A systematic review
- (2017) David V. Sheehan et al. JOURNAL OF AFFECTIVE DISORDERS
- Major Depressive Disorder and Bipolar Disorder Predispose Youth to Accelerated Atherosclerosis and Early Cardiovascular Disease
- (2015) Benjamin I. Goldstein et al. CIRCULATION
- Predictors of impaired work functioning in employees with major depression in remission
- (2015) Gabe de Vries et al. JOURNAL OF AFFECTIVE DISORDERS
- Mortality in Mental Disorders and Global Disease Burden Implications
- (2015) Elizabeth Reisinger Walker et al. JAMA Psychiatry
- A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013
- (2014) David A. Mrazek et al. PSYCHIATRIC SERVICES
- Increase in Work Productivity of Depressed Individuals With Improvement in Depressive Symptom Severity
- (2013) Madhukar H. Trivedi et al. AMERICAN JOURNAL OF PSYCHIATRY
- COGNITIVE DEFICITS AND FUNCTIONAL OUTCOMES IN MAJOR DEPRESSIVE DISORDER: DETERMINANTS, SUBSTRATES, AND TREATMENT INTERVENTIONS
- (2013) Roger S. McIntyre et al. DEPRESSION AND ANXIETY
- Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach
- (2013) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Depression in the workforce: the intermediary effect of medical comorbidity
- (2011) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorder
- (2010) Jasmina I. Ivanova et al. CURRENT MEDICAL RESEARCH AND OPINION
- What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies
- (2008) Abebaw Fekadu et al. JOURNAL OF AFFECTIVE DISORDERS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started